Think Brain Health Global newsletter – April 2021
- Think Brain Health Global: new name, new look
- Time matters in the British Journal of Neuroscience Nursing: ask the author, Ruth Trout
- Think Brain Health – a policy, clinical and research challenge: conference report
- Brain health and its management in the time of COVID-19: future implications
- Spread the word
Think Brain Health Global: new name, new look
We have updated our look and name to reflect our global ambitions! Our Steering Committee is made up of international experts and our recommendations to improve brain health are universal. We know there is always more to do, so we will continue to strive to make Think Brain Health Global accessible and applicable to all.
Time matters in the British Journal of Neuroscience Nursing: ask the author, Ruth Trout
A key member of our Steering Committee, Ruth Trout, Senior Lecturer, Buckinghamshire New University, UK, has authored a fantastic piece ‘Time matters: a call to prioritize brain health’ for the British Journal of Neuroscience Nursing. We asked her for some top-line insights, given below.
What was the key message you wanted to convey: to remind nurses of the importance of the contribution they can make to policymaking and implementation of policy.
Tell us briefly about the ‘Time matters’ report: the report calls for individuals, health practitioners and policymakers to promote brain health, consider the judicious use of risk assessment and conduct research that will inform healthcare service design and delivery, in order to optimise diagnosis and management of people with, or at risk of, neurodegenerative diseases.
What do you think we need to avert a future crisis: strong nurse leadership is needed to embrace forward-thinking and innovative ideas that will positively affect services and patients, and we must be prepared to fight for them at local and national levels, with the same passion with which we care for our patients every day.
Think Brain Health – a policy, clinical and research challenge: conference report
‘Personalized plans, blood biomarkers and early conversations’ is a summary of our fantastic first-ever conference. This covers the key topics of the 2-day conference and includes quotes from our scientific faculty. Short articles covering this summary report were published in the:
- Royal Society of Public Health newsletter
- Alzheimer’s Europe January newsletter
- European Academy of Neurology news blog.
A link to the full conference summary report is available from here.
Brain health and its management in the time of COVID-19: future implications
The COVID-19 pandemic has had a major impact on health, behaviour and risk management, psychosocial well-being and the ability of health systems to respond to ever-greater numbers of patients with complex and competing needs.
Think Brain Health Global has identified three areas for which experiences during the COVID-19 pandemic have implications for brain health and its management.
You can access our COVID-19 summary here.
Spread the word
Please show your support for the Think Brain Health Global initiative by sharing this news letter and our website with your colleagues and friends directly and via your social media feeds. They can find out more about Think Brain Health Global and sign-up to receive updates by going to the foot of any page here or find us on Twitter.
Thank you for your continuing support!
As always, if you have any further questions please do not hesitate to get in touch at: email@example.com
Dr Alastair Noyce
Chair of the Think Brain Health Global Steering Committee
On behalf of the Think Brain Health Global Steering Committee: Kris Dierickx, Giovanni Frisoni, Gavin Giovannoni, Karl Heilbron, Susan Mitchell, Ingrid Roesner, Ruth Trout, Wiesje van der Flier, Charlotte Warren-Gash.
If this newsletter has been forwarded to you by someone else and you would like to subscribe to future issues, please sign up on our ‘Get involved’ section of the website.
Follow @TBHTimeMatters on Twitter
Think Brain Health Global has been funded by grants from Biogen, F. Hoffmann-La Roche and UCB Biopharma SRL, all of whom had no influence over the content
Editorial and administrative support for the Think Brain Health Global initiative is provided by Oxford Health Policy Forum, a not-for-profit community interest company registered in England and Wales (registration number: 10475240).